Episode Details

In this discussion, Dr. Anagnostou and Dr. Greenhot review key elements for informed consent in oral immunotherapy (OIT), emphasizing the benefits, risks, and outcomes of the treatment. They highlight OIT's ability to increase allergen tolerance thresholds, while acknowledging potential risks like dose-related reactions and rare conditions such as eosinophilic gastrointestinal disorders. Alternatives to OIT, including food avoidance, emerging biologics, and clinical trial participation, are also discussed, with a focus on empowering clinicians to guide families in making informed decisions.